Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Acid-sensing ion channel 1a (ASIC1a) is a proton-gated cation channel belonging to the Degenerin/Epithelial Sodium Channel (Deg/ENaC) superfamily. It forms homotrimeric or heterotrimeric channels that are activated by extracellular acidification, leading to Na+ and Ca2+ influx. ASIC1a is primarily expressed in the central and peripheral nervous systems and plays roles in synaptic plasticity, pain sensation, and neurodegeneration following stroke. Amiloride and other pharmacological inhibitors can block the channel.
Proton-gated ion channel blocker
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Acid-sensing ion channel 1a (ASIC1a).